Dashboard
Manage Tickers

MCKPFMallinckrodt plc

OTC www.mallinckrodt.com


nm (nm)    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ na
-- x --
-- x --
-- - --
nm - nm
0
na
1.58M
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-28-2024 10-Q
2 05-09-2024 03-29-2024 10-Q
3 03-26-2024 12-29-2023 10-K
4 11-07-2023 09-29-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-03-2023 12-30-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-11-2022 07-01-2022 10-Q
10 05-03-2022 04-01-2022 10-Q
11 03-15-2022 12-31-2021 10-K
12 11-02-2021 09-24-2021 10-Q
13 08-03-2021 06-25-2021 10-Q
14 05-04-2021 03-26-2021 10-Q
15 03-10-2021 12-25-2020 10-K
16 11-03-2020 09-25-2020 10-Q
17 08-04-2020 06-26-2020 10-Q
18 05-06-2020 03-27-2020 10-Q
19 02-26-2020 12-27-2019 10-K
20 11-05-2019 09-27-2019 10-Q
21 08-06-2019 06-28-2019 10-Q
22 05-07-2019 03-29-2019 10-Q
23 02-26-2019 12-28-2018 10-K
24 11-06-2018 09-28-2018 10-Q
25 08-07-2018 06-29-2018 10-Q
26 05-08-2018 03-30-2018 10-Q
27 02-27-2018 12-29-2017 10-K
28 11-07-2017 09-29-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-08-2017 03-31-2017 10-Q
31 11-29-2016 09-30-2016 10-K
32 08-02-2016 06-24-2016 10-Q
33 05-03-2016 03-25-2016 10-Q
34 02-02-2016 12-25-2015 10-Q
35 11-24-2015 09-25-2015 10-K
36 08-04-2015 06-26-2015 10-Q
37 05-05-2015 03-27-2015 10-Q
38 02-03-2015 12-26-2014 10-Q
39 11-25-2014 09-26-2014 10-K
40 08-07-2014 06-27-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

shortage-relief-more-takedas-vyvanse-for-adhd-on-the-way-as-us-ramps-up-production
Shortage Relief: More Takeda's Vyvanse For...
09/06/2024 13:46:26

Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and gl...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION